Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012)
Achieve Life Sciences (ACHV) posted Operating Margin of 126.18% for Q3 2012, down 48.44% on a QoQ basis from 244.71% in Q2 2012, and down 22280.0% year-over-year from N/an in Q4 2011.
Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012) Analysis & Trends
Achieve Life Sciences' Operating Margin history runs 3 years deep, the most recent figure standing at 126.18% for Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 126.18% |
| Jun 30, 2012 | 244.71% |
| Mar 31, 2012 | -418.16% |
| Sep 30, 2011 | 348.98% |
| Jun 30, 2011 | 264.60% |
| Mar 31, 2011 | -435.78% |
| Sep 30, 2010 | -142.33% |
| Jun 30, 2010 | -167.72% |